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Cover The BMP antagonist Gremlin1 is secreted by glioma cancer stem cells (CSCs) to suppress the prodifferentiation effect of endogenous BMP signaling and promote self-renewal and thereby maintain the glioma hierarchy. Shown here is an immunofluorescence analysis of human glioma tissue that was stained with antibodies directed against Gremlin1 (red) and the endothelial cell marker CD31 (green) and with the DNA stain DAPI (blue). Gremlin1-positive CSCs are present in the perivascular niche. (For details, see Yan et al., p. 1085.)
